The Allergy Immunology and Cell Biology Unit at the Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, has successfully conducted whole genomic sequencing of SARS-CoV-2 variants in Sri Lanka. This groundbreaking research provides valuable insights into the changing landscape of the virus in the country. The “Report 60” contains the whole genomic sequencing...Read More
Those who wish to receive the Booster Dose are requested to produce their N.I.C., the University Identity Card and the Covid-19 Vaccination card to the concerned Health Authorities at the University vaccination centres in order to receive their Booster Dose. The second dose will also be administered to anyone who has already obtained the 1st dose. Therefore, those who have already obtained the...Read More
The vaccination programme will be conducted from 08th to 11th March 2022 at the Bandaranayake Hall of the University Premises from 9.00 a.m. to 2.00 p.m. each day. This programme is intended to vaccinate the booster dose and second dose for the students and staff under 30 years of age in State Universities and HEIs...Read More
According to the latest SARS-CoV-2 variant report issued by the Allergy Immunology and Cell Biology Unit of the Department of Immunology and Molecular Medicine of the University of Sri Jayewardenepura, 41 new cases of Omicron were detected from 176 samples. Omicron is currently detected in over 100 countries including the United States, Canada, Australia India,...Read More
The report of whole genomic sequencing of the SARS-CoV-2 variants in Sri Lanka was issued on 03.12.2021 by the Allergy, Immunology and Cell Biology Unit of the Department of Immunology Molecular and Molecular Medicine of the University of Sri Jayewardenepura. The study was carried out by USJ researchers including Prof. Neelika Malavige and Dr. Chandima Jeewandara. 94...Read More
Sri Lanka has confirmed a new sub lineage of the Delta strain of SARS-CoV-2, the virus that causes COVID-19, detected in the island and termed B.1.617.2. AY 104. Dr. Chandima Jeewadara, Director, Molecular and Cell Biology Unit of the University of Sri Jayewardenepura (USJ, said Sri Lanka now has three variants that originated in the...Read More
Prof. Neelika Malavige was selected as a member of WHO technical advisory committee on Covid-19. WHO(World Health Organization) has established a Technical Advisory Group (TAG) to advise on scientific, technical and strategic matters related to the COVID-19 Technology Access Pool (C-TAP). The group is composed of 10 renowned experts with a diverse range of knowledge...Read More
Like in other contexts in the world, the transition to online learning in Sri Lankan universities during the pandemic was sudden and abrupt: both lecturers and students had a very limited time to prepare for the new mode of teaching and learning. A study was carried out to find out the student Satisfaction with Online...Read More
The Sinopharm is an inactivated COVID-19 vaccine, which is currently given emergency use authorization by the WHO and is the main vaccine used in many Asian and Middle East Countries. A new study was carried out to determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP-CorV, by investigating the immune responses in a...Read More
USJ researchers including Prof. Neelika Malavige and Dr. Chandima Jeewandara from Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine of University of Sri Jayewardenepura have been carrying out sequencing of the SARS-CoV-2 viruses since the onset of the pandemic. With the identification of the delta variant in Sri Lanka, they also detected a...Read More
